phase readout
saveNCT03767348: Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Replimune, Inc.. Phase: PHASE2. Conditions: Non-Small Cell Lung Cancer (NSCLC), Microsatellite Instability-High (MSI-H), Non-melanoma Skin Cancer (NMSC), Cutaneous Melanoma
view source ↗
comments(0)
5-min edit window · permanent after that